Avanos Medical (NYSE:AVNS) Reaches New 52-Week Low – Time to Sell?

Avanos Medical, Inc. (NYSE:AVNS)’s stock price hit a new 52-week low on Tuesday . The company traded as low as $17.35 and last traded at $17.63, with a volume of 6665 shares traded. The stock had previously closed at $17.75.

Wall Street Analyst Weigh In

Separately, StockNews.com downgraded shares of Avanos Medical from a “strong-buy” rating to a “buy” rating in a report on Sunday, November 3rd.

Avanos Medical Stock Performance

The firm has a market cap of $743.58 million, a P/E ratio of 47.59 and a beta of 0.95. The company has a debt-to-equity ratio of 0.12, a quick ratio of 1.46 and a current ratio of 2.22. The firm’s fifty day moving average price is $19.94 and its 200 day moving average price is $21.37.

Institutional Trading of Avanos Medical

Institutional investors have recently modified their holdings of the company. Paradice Investment Management LLC raised its stake in shares of Avanos Medical by 5.4% in the second quarter. Paradice Investment Management LLC now owns 1,344,949 shares of the company’s stock worth $26,791,000 after purchasing an additional 69,389 shares during the last quarter. Geode Capital Management LLC lifted its position in shares of Avanos Medical by 1.5% in the third quarter. Geode Capital Management LLC now owns 1,054,162 shares of the company’s stock valued at $25,337,000 after acquiring an additional 16,065 shares in the last quarter. Foundry Partners LLC grew its stake in Avanos Medical by 1.1% during the 3rd quarter. Foundry Partners LLC now owns 163,030 shares of the company’s stock valued at $3,918,000 after acquiring an additional 1,800 shares in the last quarter. AQR Capital Management LLC boosted its stake in Avanos Medical by 21.0% during the second quarter. AQR Capital Management LLC now owns 146,983 shares of the company’s stock worth $2,875,000 after buying an additional 25,467 shares during the last quarter. Finally, FMR LLC increased its position in Avanos Medical by 34.6% during the third quarter. FMR LLC now owns 133,844 shares of the company’s stock worth $3,216,000 after purchasing an additional 34,421 shares during the last quarter. 95.17% of the stock is currently owned by institutional investors.

Avanos Medical Company Profile

Avanos Medical, Inc, a medical technology company, offers medical device solutions in North America, Europe, the Middle East, Africa, the Asia Pacific, and Latin America. It offers a portfolio of chronic care products that include digestive health products, such as Mic-Key enteral feeding tubes, Corpak patient feeding solutions, and NeoMed neonatal and pediatric feeding solutions.